<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05010551</url>
  </required_header>
  <id_info>
    <org_study_id>REC/00843 Rabbiya Zaman</org_study_id>
    <nct_id>NCT05010551</nct_id>
  </id_info>
  <brief_title>Translation and Validation of MPCOSQ in Urdu Language</brief_title>
  <official_title>Translation and Validation of Modified Polycystic Ovary Syndrome Questionnaire in Urdu Language</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Riphah International University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Riphah International University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To translate and validate modifies polycystic ovary syndrome quality of life (MPCOQ)&#xD;
      questionnaire into Urdu. To evaluate the reliability, validity and of Urdu version of&#xD;
      modified polycystic ovary syndrome quality of life questionnaire (MPCOQ).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  All statistical analyses will be conducted using the Statistical Product and Service&#xD;
           Solution version 21 software.&#xD;
&#xD;
        -  Continuous variables will be shown by mean and standard deviation and the categories&#xD;
           will be demonstrated in frequency and percentage.&#xD;
&#xD;
        -  In this study, factor structure of the (MPCOQ) will be analyzed using the principal&#xD;
           component factor analysis with varimax rotation.&#xD;
&#xD;
        -  Intraclass Correlation Coefficient (ICC) (95% confidence interval) will be used for&#xD;
           test-retest value and Cronbach's Alpha will be used for internal consistency analysis.&#xD;
&#xD;
        -  Measurement error will be determined by calculating the standard error of measurement&#xD;
           (SEM) and the Smallest Detectable Change (SDC). Independent t-test will be used to&#xD;
           determine the differences between groups&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Translation and validation of MPCOSQ in (Urdu) Language</measure>
    <time_frame>6 months</time_frame>
    <description>The tool is to measure health related quality of life of females suffering from PCOS. it contains 30 items with 6 main areas related to hirsutism , acne, weight, infertility, emotional disturbance, menstrual difficulties to define different symptoms of PCOS. then quality of life will be measured of respective patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reliability</measure>
    <time_frame>6 months</time_frame>
    <description>To determine reliability of MPSOCQ in (URDU) language. reliability refers to ability of a measure to produce same results administered at two or more intervals. Thus this will be test through test retest reliability</description>
  </secondary_outcome>
  <other_outcome>
    <measure>validity</measure>
    <time_frame>6 months</time_frame>
    <description>to determine the validity of translation of MPCOSQ in (URDU) language. Validity is defined as how accurate the results are. Thus this will be measured through various parameters</description>
  </other_outcome>
  <enrollment type="Anticipated">180</enrollment>
  <condition>PCOS- Polycystic Ovary Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with PCOS&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Age 18 - 30&#xD;
&#xD;
               -  Married&#xD;
&#xD;
               -  Female patients diagnosed with PCOS, having 2 of the following Rotterdam&#xD;
                  diagnostic criteria:&#xD;
&#xD;
        I. Polycystic ovaries visualized on ultrasound scan (presence of 12 follicles or more in&#xD;
        one or both ovaries and/or increased ovarian volume &gt;10ml II. Clinical signs of&#xD;
        hyperandrogenism (the hirsutism score based on the Ferriman-Gallwey score &gt;7 or obvious&#xD;
        acne) III. Having an interval between menstrual periods &gt;35 days and/or amenorrhea as the&#xD;
        absence of vaginal bleeding for at least 6 months, i.e. 199 days Patients who are willing&#xD;
        to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Non-adrenal hyperplasia, thyroid dysfunction, and hyperprolactinemia&#xD;
&#xD;
               -  Female undergoing Hormone Replacement Therapy&#xD;
&#xD;
               -  Female with malignancies&#xD;
&#xD;
               -  Any recent fractures, surgeries&#xD;
&#xD;
               -  Patient with nephrological and neurological conditions&#xD;
&#xD;
               -  Dementia or cognitive impairments&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Married Diagnosed with PCOS</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Ehsan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Riphah International University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abeer Fatima, MS(cppt)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Riphah International University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rabbiya Zaman, MSPT(whpt)</last_name>
    <phone>0309-4039614</phone>
    <email>rabbiyazaman87@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Abeer Fatima</name>
      <address>
        <city>Islamabad</city>
        <state>Punjab</state>
        <zip>45000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abeer Fatima, MSPT (CPPT)</last_name>
      <phone>03362645208</phone>
      <email>abeer1.fatima@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>SARAH EHSAN</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Zohra Institute of Health Sciences</name>
      <address>
        <city>Rawalpindi</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abeer Fatima, Ms(CPPT)</last_name>
      <phone>03362645208</phone>
      <email>abeer1.fatima@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>SARAH EHSAN</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 11, 2021</study_first_submitted>
  <study_first_submitted_qc>August 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2021</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

